查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1195576

防粘連材料市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Adhesion Barrier Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預測期內，防粘連材料市場的複合年增長率預計為 7.9%。

在 COVID-19 大流行期間，外科醫生實施並遵守了針對每個專業的嚴格指南，以便繼續為患者提供安全有效的護理。對治療產生了重大影響 例如，根據 BMJ 雜誌 2021 年 6 月發表的一篇文章，外科項目在大流行期間暫停了世界各地的各種非緊急或選擇性外科手術。 這些變化對患者、提供者和醫療保健組織產生了相當大的影響。 因此，在 COVID-19 大流行期間外科手術的減少對 2020 年的市場增長產生了負面影響。 然而，推遲的手術在大流行後恢復，推動了市場增長。 隨著大流行的消退，預計研究市場將在預測期內顯著增長。 市場增長的具體驅動因素包括手術和運動相關傷害的增加，以及對粘連的醫學影響的認識提高。

根據英國心臟基金會 2021 年 12 月發布的數據，2021 年 10 月英國估計完成了 32,938 例心臟手術，包括心臟手術。 粘連屏障是在手術後使用的，因此預計未來會有更多需要粘連屏障來減少疤痕的手術和手術。 因此，預計市場將在預測期內飆升。

此外，由於運動損傷和事故以及骨科手術導致的外科手術數量增加是推動粘連屏障市場的主要因素。 許多骨科疾病和其他慢性疾病表明必須進行手術。 根據美國國家安全委員會（NSC）公佈的 2021 年美國數據，騎車受傷約佔 375,797 人，運動受傷約佔 409,224 人。 全地形車 (ATV)、輕便摩托車和小型自行車造成 238,404 人受傷，滑板、踏板車和氣墊板造成 245,177 人受傷。 因此，預計受傷人數的增加將推動粘合劑屏障市場的全球增長。

發展中國家的醫療保健正在迅速變化。 隨著這些國家人口的增加，對醫療設備的需求也會增加。 不斷增加的疾病負擔和創新的醫療方法佔支出增長的近三分之二。 在預測期內，發展中國家的醫療保健支出預計會增加。 英國國家統計局 2022 年 5 月公佈的數據顯示，2021 年的醫療保健總支出估計為 2770 億英鎊（3734 億美元），比上年增長 7.4%。 對醫療保健行業的具體投資可提供有吸引力的長期經濟回報。 隨著收入的增加，醫療保健是個人傾向於增加支出的一個領域。 因此，隨著醫療成本的增加，手術粘合劑等先進產品的採用預計會增加。 因此，該研究涵蓋的市場有望在研究預測期內實現增長。

因此，由於上述因素（例如手術和運動相關損傷的數量增加、醫療費用增加以及對粘連的醫學影響的認識不斷提高），研究中的市場預計會出現增長。 然而，外科手術的高成本加上□□與粘連屏障相關的副作用以及限制創新的嚴格法規預計將抑制粘□□連屏障市場的增長。

防粘連材料市場趨勢

婦科手術行業有望增長

粘連病是術後患者發病的重要原因。 抗粘連屏障已被證明可以減少婦科手術中與粘連相關的並發症。 在開放手術中使用粘連屏障在預防粘連相關問題方面具有成本效益。

根據世衛組織 2021 年 6 月的最新消息，剖宮產在全球範圍內繼續增加，佔分娩的五分之一 (21%) 以上。 此外，由於非傳染性疾病和傷害的負擔增加，一些國家的外科手術也在增加。 此外，根據美國疾控中心2022年7月公佈的數據，2021年美國的剖宮產率將上升至32.1%。 剖腹產是一種需要使用粘連屏障的腹部手術。

此外，根據2021年8月發表在《婦產科學雜誌》上的一篇論文，婦科手術後的粘連形成很普遍，直接誘發並發症，給後續手術帶來困難，所以問題很大。 防粘連屏障已被證明可以安全有效地解決這個問題。 與未經處理的對照相比，粘連屏障有助於顯著降低粘連的範圍和嚴重程度。

因此，由於上述因素，例如婦科手術的增加以及婦科手術中抗粘連材料的益處增加，預計該行業在預測期內將出現顯著增長。

預計北美將佔據較大的市場份額

該地區手術率的增加是有據可查的。 北美市場的增長受到技術進步、期望更高水平功能的老年患者以及激勵複雜融合手術的報銷模式的推動。 粘附屏障也可用於腫瘤手術。 此外，人們越來越意識到因受傷和慢性病問題而接受外科手術也推動了市場增長。

北美地區骨科手術數量的增加預計將對市場增長產生積極影響。 例如，根據美國骨科醫師學會 2022 年 11 月發布的數據，2010 年美國估計進行了 2,550,232 例初次和翻修髖關節和膝關節置換術。 與上一年相比，累積程序技能增加了 14%。 由於骨科手術中使用了粘連屏障，因此髖關節和膝關節手術數量的增加有望推動市場增長。

此外，根據美國國家安全委員會 (NSC) 2021 年發布的數據，估計有 1170 萬人因消費品受傷在美國急診室接受治療。 許多傷害涉及通常被認為安全的日常用品。 許多傷害發生在弱勢群體，例如老人和幼兒。 根據加拿大健康信息研究所 2022 年 2 月的數據，剖腹產是 2021 年加拿大最常見的住院手術。 因此，預計防粘連屏障的採用將會增加。 因此，預計在預測期內，越來越多的需要醫療護理的傷害和越來越多的手術數量將進一步推動該地區的市場。

因此，上述所有因素（例如受傷病例的增加和骨科手術的增加）預計都將提振該地區的市場。

防粘連材料市場競爭者分析

防粘連材料市場競爭適中，由幾家大型企業組成。 Anika Therapeutics、Baxter International、Leader Biomedical、Betatech Medical、FzioMed、Integra LifeSciences Holdings Corporation、強生和 MAST Biosurgery 等公司在抗粘連市場佔有重要的市場份額。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 調查先決條件和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 手術和運動相關傷害的增加
    • 對粘連的醫學影響的認識不斷提高
  • 市場製約因素
    • 高昂的手術費用和與抗粘連屏障相關的副作用
    • 通過嚴格的監管限制技術創新
  • 行業吸引力 - 波特五力分析
    • 新進入者的威脅
    • 買家的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 按產品分類
    • 合成粘合劑屏障
      • 透明質酸
      • 再生纖維素
      • 聚乙二醇
      • 其他合成粘合劑
    • 天然膠
      • 膠原蛋白
      • 纖維蛋白
  • 按劑型
    • 電影
    • 液體
    • 凝膠
  • 通過使用
    • 普通外科/腹部外科
    • 婦科
    • 心血管外科
    • 骨科
    • 神經外科
    • 其他用途
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Anika Therapeutics
    • Baxter International
    • Leader Biomedical
    • Betatech Medical
    • FzioMed
    • BIOSCOMPASS, INC.
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson
    • GUNZE LIMITED
    • Wuhan Sitaili Medical Apparatus Development Co.
    • TAICEND TECHNOLOGY CO., LTD
    • MAST Biosurgery

第7章 市場機會今後動向

簡介目錄
Product Code: 67614

The adhesion barrier market is expected to register a CAGR of 7.9% over the forecast period.

The pandemic had a significant impact on various surgical procedures initially, as there were strict guidelines specific to each specialty that was implemented and followed by surgeons to continue to provide safe and effective care to their patients during the COVID-19 pandemic. For instance, according to an article published by BMJ Journal in June 2021, surgical programs suspended various non-urgent or elective surgical procedures worldwide during the pandemic. These changes considerably impacted patients, providers, and healthcare organizations. Thus, reducing surgical procedures during the COVID-19 pandemic negatively impacted the market's growth in 2020. However, the postponed surgeries resumed during the post-pandemic period, which boosted the market's growth. As the pandemic has subsided, the studied market is expected to grow significantly over the forecast period. Specific factors driving the market growth include increased surgeries and sports-related injuries and rising awareness about the medical implications of adhesions.

According to the data published by British Heart Foundation in December 2021, an estimated 32,938 completed heart operations and other heart procedures were performed in England in October 2021. As adhesion barriers are used after surgeries, increasing operations and surgeries are expected to require adhesion barriers to reduce scars. Therefore, the market is expected to surge over the forecast period.

Moreover, a growing number of surgical procedures due to sports injuries, accidents, and orthopedic surgeries are primary factors driving the adhesion barrier market. There is a high prevalence of orthopedic diseases and other chronic conditions where surgery is suggested as mandatory. According to the data published by the National Safety Council (NSC) for the United States in 2021, bicycling accounted for about 375,797 injuries, and exercise accounted for about 409,224 injuries. The injuries due to an all-terrain vehicle (ATV), moped, and minibike were 238,404, and those due to skateboard, scooter, and hoverboard were 245,177. Therefore, an increasing number of injuries is expected to propel the growth of the adhesion barrier market globally.

Healthcare in developing countries is undergoing rapid changes. The growing population in these countries will likely lead to increased demand for medical devices. The growing burden of diseases and innovative medical treatments contributed to nearly two-thirds of the rise in spending. Spending on healthcare in developing countries is expected to increase during the forecast period. According to the data published by the Office for National Statistics of the United Kingdom in May 2022, the estimated total healthcare expenditure in 2021 was GBP 277 billion (USD 373.4 billion), which increased by 7.4% when compared to the spending in the last year. Specific investments in the healthcare sector offer attractive long-term financial benefits. Medical care is one area where individuals tend to increase spending as incomes grow. Hence, with the increasing healthcare expenditure, the adoption of advanced products, such as adhesion barriers for surgeries, is expected to increase. Thus the studied market is expected to experience growth during the forecast period of the study.

Therefore, due to the aforementioned factors, such as the increased volume of surgeries and sports-related injuries, increasing healthcare expenditure, and rising awareness about the medical implications of adhesions, the studied market is expected to experience growth. However, the high cost of surgical procedures coupled with side effects associated with adhesion barriers and stringent regulations resulting in limited technological innovations are expected to restrain the growth of the adhesion barrier market.

Adhesion Barrier Market Trends

Gynecological Surgeries Segment Expected to Witness Growth

The adhesive disease represents a significant cause of morbidity for postoperative patients. Adhesion barriers have been proven to reduce adhesion-related complications in gynecological surgery. The use of adhesion barriers in open surgery is cost-effective in preventing adhesion-related problems.

According to the WHO updates from June 2021, cesarean section procedures are continuously rising globally, accounting for more than 1 in 5 (21%) childbirths. Moreover, several countries are also experiencing a rise in surgical procedures owing to the rising burden of non-communicable diseases and injuries. Furthermore, per the data published by CDC in July 2022, the cesarean delivery rate increased to 32.1% in the United States in 2021. Cesarean delivery is an abdominal surgery that requires the use of adhesion barriers.

Furthermore, according to an article published by the Journal of Obstetrics and Gynaecology in August 2021, adhesion formation after gynaecologic surgeries is widespread and highly problematic as it directly induces complications and makes subsequent surgeries more difficult. Adhesion barriers to overcoming this problem have proven safe and effective. Adhesion barriers help in significantly reducing both adhesion extent and severity in comparison to untreated control.

Thus, the segment is expected to witness significant growth over the forecast period due to the above-mentioned factors, such as increasing gynecological surgeries and increasing advantages of adhesion barriers in gynecological surgeries.

North America Anticipated to Hold a Significant Market Share

The increasing rate of surgery in the region has been well-documented. Market growth in North America is driven by technological advancement, elderly patients expecting higher levels of function, and reimbursement models incentivizing complex fusion surgery. Adhesion barriers are also valuable for oncology surgeries. Furthermore, growing awareness among the population to approach surgical procedures in case of injuries and chronic disease problems is also driving market growth.

The rising number of orthopedic procedures within the North American region will likely positively impact market growth. For instance, according to the data published by the American Academy of Orthopedic Surgeons in November 2022, an estimated 2,550,232 primary and revision hip and knee arthroplasty procedures were performed in the decade in the United States. It showed a cumulative procedural volume growth of 14% compared to the previous year. As adhesion barriers are used for orthopedic procedures, the increasing number of hip and knee arthroplasty procedures is expected to enhance the market growth.

Additionally, according to the data published by National Safety Council (NSC) in 2021, an estimated 11.7 million people were treated in emergency departments of the United States for injuries resulting from consumer products. Most injuries involve everyday products that are often assumed to be safe. Many injuries occur to vulnerable populations such as older adults and young children. According to the Canadian Institute of Health Information data in February 2022, the most common inpatient surgery in Canada in 2021 was a cesarean section (C-section). This is expected to increase the adoption of adhesion barriers. Thus, the increasing number of injuries that require medical attention and a growing number of surgeries is further expected to boost the market in the region over the forecast period.

Thus, all the aforementioned factors, such as the rise in injury cases and the rising number of orthopedic surgeries, are expected to boost the market in the region.

Adhesion Barrier Market Competitor Analysis

The adhesion barrier market is moderately competitive and consists of several major players. Companies such as Anika Therapeutics, Baxter International, Leader Biomedical, Betatech Medical, FzioMed, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and MAST Biosurgery, among others, hold a substantial market share in the adhesion barrier market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in the Volume of Surgeries and Sports-related Injuries
    • 4.2.2 Rising Awareness about the Medical Implications of Adhesions
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Surgical Procedures Coupled with Side Effects Associated with Adhesion Barriers
    • 4.3.2 Stringent Regulations Resulting in Limited Technological Innovations
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Synthetic Adhesion Barriers
      • 5.1.1.1 Hyaluronic Acid
      • 5.1.1.2 Regenerated Cellulose
      • 5.1.1.3 Polyethylene Glycol
      • 5.1.1.4 Other Synthetic Adhesion Barriers
    • 5.1.2 Natural Adhesion Barriers
      • 5.1.2.1 Collagen
      • 5.1.2.2 Fibrin
  • 5.2 By Formulation
    • 5.2.1 Film
    • 5.2.2 Liquid
    • 5.2.3 Gel
  • 5.3 By Application
    • 5.3.1 General/Abdominal Surgeries
    • 5.3.2 Gynecological Surgeries
    • 5.3.3 Cardiovascular Surgeries
    • 5.3.4 Orthopedic Surgeries
    • 5.3.5 Neurological Surgeries
    • 5.3.6 Other Applications
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Anika Therapeutics
    • 6.1.2 Baxter International
    • 6.1.3 Leader Biomedical
    • 6.1.4 Betatech Medical
    • 6.1.5 FzioMed
    • 6.1.6 BIOSCOMPASS, INC.
    • 6.1.7 Integra LifeSciences Holdings Corporation
    • 6.1.8 Johnson & Johnson
    • 6.1.9 GUNZE LIMITED
    • 6.1.10 Wuhan Sitaili Medical Apparatus Development Co.
    • 6.1.11 TAICEND TECHNOLOGY CO., LTD
    • 6.1.12 MAST Biosurgery

7 MARKET OPPORTUNITIES AND FUTURE TRENDS